Global Intrauterine Devices (IUD) Market Overview
The global intrauterine devices (IUD) market is projected to grow from an estimated US$ 5.34 billion in 2023 to US$ 7.53 billion by 2032, representing a compound annual growth rate (CAGR) of 3.88% from 2024 to 2032. The expansion of this market is driven by the increasing awareness of effective, long-term contraceptive options, technological advancements in IUDs, and supportive government initiatives for reproductive health and family planning.
Request a free sample copy of the report: https://www.renub.com/intrauterine-devices-market-p.php
Intrauterine Devices: Market Dynamics and Growth Drivers
1. Rising Awareness of Long-Term Contraceptives
o Increased education on the safety, reliability, and convenience of IUDs is fueling adoption rates globally. IUDs are particularly attractive for women seeking long-term, reversible birth control with minimal maintenance. Initiatives like the U.S. Department of Health and Human Services’ Title X program and coverage mandates under the Affordable Care Act (ACA) have made long-acting reversible contraceptives (LARCs) more accessible, especially among underserved populations. In 2022, the Centers for Disease Control and Prevention (CDC) reported an increase in LARC use among U.S. women aged 15-49, with utilization reaching 11%.
2. Advances in IUD Technology
o New designs and delivery mechanisms have improved patient comfort and safety, expanding the IUD market to a broader demographic. Recent innovations in hormonal IUDs provide not only contraceptive benefits but also address health conditions like heavy menstruation and dysmenorrhea. Moreover, applications of AI and telemedicine are enhancing service accessibility, especially in remote regions, contributing to market growth.
3. Supportive Healthcare Programs and Policies
o Government campaigns globally have helped raise awareness about family planning options, particularly the effectiveness and convenience of IUDs over short-term contraceptive methods. Efforts by healthcare providers and non-profit organizations to promote IUD use continue to build trust and acceptance, leading to increased market penetration.
Regional Market Insights
- Europe: Europe sees a robust adoption of IUDs, supported by well-established healthcare systems and growing demand for long-term contraception options. Germany, in particular, has a dynamic IUD market, with strong public health infrastructure promoting the use of both hormonal and copper IUDs.
- Middle East and Africa: Saudi Arabia’s IUD market is expanding, with government-backed programs focusing on women's reproductive health. Similarly, South Africa benefits from public health campaigns promoting IUDs as viable family planning options, often in partnership with non-governmental organizations.
Related Report:
Bariatric Surgery Devices Market
Key Industry Players
Leading companies in the IUD market are actively investing in R&D and strategic partnerships to expand access to IUDs globally. Major players include AbbVie Inc., Bayer AG, Teva Pharmaceuticals, ANI Pharmaceuticals, Mylan NV, CooperSurgical Inc., and DKT International.
Recent Company Developments
- January 2024: DKT WomanCare partnered with Medicines360 to expand access to AVIBELA, a high-efficacy hormonal IUD, targeting underserved communities.
- June 2023: Pregna International Limited secured a $16 million investment from India Life Sciences Fund III, aimed at enhancing reproductive health options worldwide.
- August 2022: The FDA approved Bayer AG’s new usage extension for the Mirena IUD, allowing it to be effective for up to eight years.
Market Segmentation
The IUD market can be segmented by type and end-use:
- Type: Hormonal IUDs and Copper IUDs
- End Use: Hospitals, Gynecology Clinics, Community Health Centers, and Others
Table of Contents
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Intrauterine Devices Market
6. Market Share Analysis
6.1 By Type
6.2 By End Use
6.3 By Countries
7. Type
7.1 Hormonal IUD
7.2 Copper IUD
8. End Use
8.1 Hospital
8.2 Gynecology Clinics
8.3 Community Health Care Centers
8.4 Others
9. Countries
9.1 North America
9.1.1 United States
9.1.2 Canada
9.2 Europe
9.2.1 France
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 United Kingdom
9.2.6 Belgium
9.2.7 Netherlands
9.2.8 Turkey
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Thailand
9.3.6 Malaysia
9.3.7 Indonesia
9.3.8 Australia
9.3.9 New Zealand
9.4 Latin America
9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina
9.5 Middle East & Africa
9.5.1 Saudi Arabia
9.5.2 UAE
9.5.3 South Africa
10. Porter’s Five Forces Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis
11.1.1 Strength
11.1.2 Weakness
11.1.3 Opportunity
11.1.4 Threat
12. Key Players Analysis
12.1 AbbVie Inc.
12.1.1 Overview
12.1.2 Key Persons
12.1.3 Recent Development & Strategies
12.1.4 Revenue Analysis
12.2 Bayer AG
12.2.1 Overview
12.2.2 Key Persons
12.2.3 Recent Development & Strategies
12.2.4 Revenue Analysis
12.3 Teva Pharmaceuticals
12.3.1 Overview
